|
Mixture of Estrogens Selective for Estrogen Receptor Beta for Treatment of Neurological or Psychiatric Disorders
This technology provides a mixture of estrogens that are selective for ER-β activation, offering a novel treatment for neurological and psychological disorders.
Background:
Mental disorders are the number one contributor to non-communicable diseases worldwide. Mental disorders such as schizophrenia, mood disorders, substance abuse and dementia...
Published: 4/3/2023
|
Inventor(s): Robert Handa, Jill Goldstein, Stuart Tobet
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Healthcare Portfolios > Neurology, Technology Classifications > Healthcare Portfolios > Immunology, Autoimmune & Inflammation
|
